Brief
Warp Sciences funding hits $215M for robotic drug labs
Former OpenAI science leader Kevin Weil has launched Warp Sciences with $215 million in funding at an $865 million valuation. The startup plans to use AI-trained robots to automate chemical synthesis and laboratory testing and accelerate drug discovery.